Therapeutic compounds
US11560360B2 · kind B2 · utility
0Cited by
13References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 9, 2020 |
| Grant date | Jan 24, 2023 |
| Priority date | — |
| Expiry date | Jul 9, 2040 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D279/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides compounds having the general formula I: and pharmaceutically acceptable salts thereof, wherein the variables R1, R2, R3, R4, subscript m and n, have the meaning as described herein, and compositions containing such compounds and methods for using such compounds and compositions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.